
Leukemia/medlineplus.gov
Mar 24, 2025, 13:50
Novel mechanisms of resistance in Chronic lymphocytic leukemia – Blood Journal
Blood Journal shared a paper Constantine S. Tam and colleagues authored on X:
“Bruton tyrosine kinase inhibitors are an established standard of care in chronic lymphocytic leukemia.”
Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared this post, adding:
“Great review Blood Journal!
Our study on BTK mutations kinase impaired and kinase proficient responding to degraders with Nurix Therapeutics and MSKCC is in the STAT Madness 2025 competition! Read more and vote here.”
Authors: Constantine S. Tam, Shalini Balendran, Piers Blombery
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 24, 2025, 13:50
Mar 24, 2025, 13:48
Mar 24, 2025, 13:40
Mar 24, 2025, 13:28
Mar 24, 2025, 13:17
Mar 24, 2025, 13:11